Bard Peripheral Vascular, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$51.4M
Doctors Paid
17,855
Transactions
81,041
2024 Total
$6.2M
Payment Breakdown by Category
Royalty/License$15.3M (29.7%)
Research$11.0M (21.4%)
Consulting$7.1M (13.7%)
Food & Beverage$3.1M (6.0%)
Travel$1.4M (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $15.3M | 136 | 29.7% |
| Unspecified | $11.0M | 1,678 | 21.4% |
| Acquisitions | $7.8M | 18 | 15.2% |
| Consulting Fee | $7.1M | 2,498 | 13.7% |
| Food and Beverage | $3.1M | 70,803 | 6.0% |
| Honoraria | $1.6M | 576 | 3.1% |
| Travel and Lodging | $1.4M | 3,526 | 2.7% |
| Gift | $895,728 | 470 | 1.7% |
| Space rental or facility fees (teaching hospital only) | $820,109 | 83 | 1.6% |
| Education | $810,813 | 730 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $806,917 | 376 | 1.6% |
| Grant | $617,637 | 84 | 1.2% |
| Debt forgiveness | $195,948 | 8 | 0.4% |
| Long term medical supply or device loan | $67,693 | 40 | 0.1% |
| Charitable Contribution | $46,930 | 11 | 0.1% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $4,494 | 3 | 0.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $743.86 | 1 | 0.0% |
Payments by Type
General
$40.4M
79,363 transactions
Research
$11.0M
1,672 transactions
Ownership
$0
6 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| AVeNEW | $1.2M | 8 | 114 |
| AVeNEW PAS | $716,992 | 3 | 49 |
| Lutonix AV PAS CL003301 | $552,855 | 0 | 58 |
| ULTRASCORE REGISTRY BPV16001 | $528,787 | 5 | 72 |
| VERNACULAR | $512,474 | 4 | 69 |
| AVENEW BPV14005 | $511,623 | 7 | 47 |
| CONNECT-AV | $507,554 | 0 | 27 |
| VERNACULAR BPV14007 | $497,511 | 2 | 56 |
| AVeVA | $482,034 | 0 | 66 |
| UltraScore Registry BPV16001 | $450,596 | 1 | 75 |
| SAFE-DCB Registry | $399,470 | 1 | 278 |
| SAFE-DCB REGISTRY BPV14006 | $328,345 | 0 | 154 |
| AVeNEW BPV14005 | $286,945 | 2 | 22 |
| MONARCH BPV18001 | $255,628 | 1 | 33 |
| ARCH | $235,009 | 0 | 20 |
| SAFE-PAD study | $214,306 | 0 | 2 |
| CVC-PMCF | $213,979 | 0 | 9 |
| LTHC | $202,575 | 0 | 7 |
| Lutonix AV (PAS) | $181,731 | 0 | 19 |
| AVEVA BPV15001 | $175,939 | 3 | 34 |
| Lutonix BTK Trial CL000501 | $161,773 | 0 | 65 |
| WavelinQ US Post-Market Study BPV18002 | $158,828 | 0 | 13 |
| Lutonix AV PAS | $157,874 | 0 | 18 |
| Ports- MDR | $148,805 | 0 | 6 |
| SAFE-PAD STUDY | $148,131 | 0 | 1 |
| BAVC | $139,675 | 0 | 7 |
| LUTONIX BTK TRIAL CL000501 | $122,489 | 2 | 38 |
| ARCH BDPI-20-004 | $121,304 | 0 | 11 |
| LUTONIX AV PAS CL003301 | $93,209 | 0 | 9 |
| Venclose BDPI-21-006 | $91,063 | 0 | 7 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Richard Chesbrough, Md, MD | Diagnostic Radiology | Bingham Farms, MI | $15.2M | $0 |
| Craig Walker, Md, MD | Cardiovascular Disease | Houma, LA | $2.5M | $0 |
| Jeffrey Carr, Md, MD | Interventional Cardiology | Tyler, TX | $1.6M | $0 |
| Richard Gitter, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Metairie, LA | $1.5M | $0 |
| Puneet Khanna, M.d, M.D | Cardiovascular Disease | Rancho Mirage, CA | $799,846 | $0 |
| Dr. Jihad Mustapha, M.d, M.D | Cardiovascular Disease | Grand Rapids, MI | $789,355 | $0 |
| Riad Salem, Md, MD | Vascular & Interventional Radiology | Chicago, IL | $422,946 | $0 |
| Stephen Hohmann, Md, MD | Specialist | Dallas, TX | $380,621 | $0 |
| Robert Lewandowski, Md, MD | Vascular & Interventional Radiology | Chicago, IL | $325,813 | $0 |
| Ziv Haskal, M.d, M.D | Vascular & Interventional Radiology | Charlottesville, VA | $314,561 | $0 |
| Dr. David Allie, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Lafayette, LA | $301,392 | $0 |
| Bart Dolmatch, M.d, M.D | Vascular & Interventional Radiology | Mountain View, CA | $299,813 | $0 |
| Paul Mcneill, Md, MD | Vascular Surgery | Frederick, MD | $299,795 | $0 |
| Dr. Tim Fischell, Md, MD | Interventional Cardiology | Kalamazoo, MI | $248,123 | $0 |
| Dr. Fakhir Elmasri, M. D, M. D | Diagnostic Radiology | Lakeland, FL | $196,589 | $0 |
| Dr. Todd Berland, M.d, M.D | Surgery | New York, NY | $187,386 | $0 |
| Samuel Steerman, M.d, M.D | Surgery | Virginia Beach, VA | $186,600 | $0 |
| Scott Trerotola, Md, MD | Vascular & Interventional Radiology | Philadelphia, PA | $177,983 | $0 |
| Lawrence Whitney, M.d, M.D | Vascular & Interventional Radiology | Lakeland, FL | $176,804 | $0 |
| Dirk Baumann, M.d, M.D | Surgery | Burlingame, CA | $171,316 | $0 |
| Dr. Alejandro Alvarez, Md, MD | Nephrology | Florissant, MO | $166,879 | $0 |
| Dr. Angelo Makris, Md, MD | Vascular & Interventional Radiology | Westmont, IL | $157,717 | $0 |
| Richard Kovach, Md, MD | Cardiovascular Disease | Browns Mills, NJ | $153,772 | $0 |
| Robert Beasley, Md, MD | Vascular & Interventional Radiology | Miami, FL | $149,803 | $0 |
| Dr. Neghae Mawla, Md, MD | Nephrology | Plano, TX | $142,914 | $0 |
Ad
Top Products
- UltraClip II Breast Tissue Marker $6.8M
- ULTRACLIP $3.9M
Associated Products (72)
- UltraClip II Breast Tissue Marker $6.8M
- ULTRACLIP $4.8M
- LUTONIX $3.2M
- BPV-BARD Chesbrough $2.3M
- COVERA $1.8M
- CHESBROUGH $1.6M
- ULTRASCORE $1.1M
- CROSSER $470,458
- WAVELINQ $439,151
- Lutonix Drug Coated Balloon $413,989
- Venclose Maven Catheter $386,503
- CATERPILLAR $285,237
- WavelinQ $275,595
- FLUENCY $258,718
- VENOVO $254,370
- BPV-Fluency $208,396
- BPV-CROSSER $188,235
- LIFESTENT $174,821
- PleurX $168,680
- Rotarex $130,530
- BPV-Crosser Catheter $130,236
- BPV-Lifestent $125,287
- Venovo $124,367
- RotarexS 6 F x 135 cm $122,952
- LIFESTREAM $122,044
- LUTONIX Drug Coated Balloon $106,991
- FLAIR $97,093
- PER-Q-CATH $88,759
- BPV-Flair $83,867
- MISSION $83,510
- Crosser iQ $75,724
- BPV-PowerPort $75,346
- DENALI $73,752
- BPV-Ultraverse $70,224
- ENCOR $69,534
- Pristine $67,988
- CONQUEST $63,538
- BPV-True $49,395
- Liverty $49,115
- POWERPORT $46,008
- BPV-Denali $42,907
- BPV-Conquest $42,166
- DORADO $30,810
- EnCor $29,388
- CLEARVUE $29,136
- GLIDEPATH $24,782
- BPV-Marquee $24,261
- Fluency Endovascular Stent Graft $22,890
- BPV-BARD Ostycut $22,655
- LIFESTAR $22,544
- MARQUEE $22,214
- BPV-EnCor Enspire $22,202
- Trek $21,920
- BPV-BARD Mission $21,721
- BPV-ENCOR $21,311
- RotarexS 8 F x 110 cm $21,023
- RADPICC $19,671
- BPV-Seeker $18,865
- SEEKER $16,007
- Lutonix DCB $15,940
- BPV-ClearVUE $15,194
- PRESTO $14,035
- ENCOR ENSPIRE $13,947
- BPV-Reliance XK Catheter $13,944
- BPV-Glidepath Catheter $13,624
- Denali Vena Cava Filter $13,490
- Lutonix $13,050
- ULTRAVERSE $12,751
- BPV-PORTER $12,316
- VACCESS $11,931
- BPV-Atlas $11,734
- BPV-PowerHickman $10,343
Payment Categories
- Food & Beverage $3.1M
- Consulting $7.1M
- Travel & Lodging $1.4M
- Research $11.0M
- Royalties $15.3M
About Bard Peripheral Vascular, Inc.
Bard Peripheral Vascular, Inc. has made $51.4M in payments to 17,855 healthcare providers, recorded across 81,041 transactions in the CMS Open Payments database. In 2024, the company paid $6.2M. The top product by payment volume is UltraClip II Breast Tissue Marker ($6.8M).
Payments were distributed across 191 medical specialties. The top specialty by payment amount is Diagnostic Radiology ($17.8M to 3,109 doctors).
Payment categories include: Food & Beverage ($3.1M), Consulting ($7.1M), Research ($11.0M), Travel & Lodging ($1.4M), Royalties ($15.3M).
Bard Peripheral Vascular, Inc. is associated with 72 products in the CMS Open Payments database, including UltraClip II Breast Tissue Marker, ULTRACLIP, and LUTONIX.